ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine

Background: Pain management with conventional opioids can be challenging due to doselimiting adverse events (AEs), some of which may be related to the simultaneous activation of [beta]-arrestin (a signaling pathway associated with opioid-related AEs) and G-protein pathways. The investigational analg...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of pain research 2019-11, p.3113
Hauptverfasser:	Mace, Sharon E, Hammer, Gregory B, Pan, Peter H, Brzezinski, Marek, Berkowitz, Richard D, Bergese, Sergio D, Beard, Timothy L, Cochrane, Kristina, Habib, Ashraf S, Minkowitz, Harold S, Wase, Linda
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute pain Analgesia Analgesics Care and treatment Clinical trials Constipation Hospital patients Labels Medical research Nausea Opioids Pain management Safety and security measures
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!